I am a statistician, breast cancer survivor, and mother of two girls. I have been actively blogging on wordpress.com since 2009 (when I was diagnosed with breast cancer) talking about my daily life (cancer, children, education and travel etc). In this blog, I will focus on statistics/programming/oncology related topics.
I am a statistican working with a pharmaceutical/healthcare company. Because I am a cancer patient by myself, I am very passional about oncology drug development, not just apply my statistical and programming skills, but also to be knowledgeable in cancer area. My daily work is designing clinical trials, analyzing and intepreting data to evaluate efficacy and safety of cancer drugs. I have a wealth of exprience in exploratory biomarker works, to understand biology of disease and try to develop targeted therapy.
Before I joined industry, I have worked in academia as postdoc/research associate for five years in Sweden and UK. My research was mainly in Bayesian Inference. My undergraduate degree was “Computational Mathematics and Applied software”, I have been enthusiasm in programming and even got certificate in C programming. Now I use R most of time. So in addition to daily drug developement work, I provide statistics/programming training to my colleagues.
Disclaimer: The views represented here are my own and do not represent the views of Roche UK.
PhD in Mathematical Statistics, 2003
Zhejiang University, China
BSc in Computational Mathematics and Applied Software, 1998
Zhejiang University, China
As a statistician working in drug development, I work at study level, project level and franchise level. I now work on clinical trials of three breast cancer drugs. I have been Hematology Franchise Biomarker Biostats Lead during 2013 - 2017 working closely with biomarker scientists to develop the biomarker strategy and leading some statistical analyses. I have also led project level safety reporting from 2012 to 2014 for one molecular, including first RMP (Risk Management Plan) and SCS (Summary of Clinical Safety) for regulatory filing.
Experimental Statistician’s work focused on PHC (Personalized Healthcare) aspect, but also with opportunity to work on other areas. I have conducted Meta-analysis for serotype biomarker. I have also implemented the first Comparative benefit risk (CBR) analysis within company for regulatory filing.
Before I joined Roche, I have worked for five years in Academia, as Post-doc/Research Associate, Statistical Geneticist at Universities in Sweden and UK. My research focused on Bayesian Inference in Computation Biology.
I provide training for my colleagues: